ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)

Generic Name: pancrelipase

Pill imprint ETH 416 has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U.

Plaretase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ETH 416

Plaretase Lipase 8,000 U / Amylase 30,000 U /  Protease 30,000 U ETH 416
Plaretase
Generic Name:
pancrelipase
Imprint:
ETH
416
Strength:
Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U
Color:
Tan
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ethex Corporation
National Drug Code (NDC):
58177-0416

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)